ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      85.155
      0.44%
      Bitcoin
      64,886.97
      -0.39%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Idera Pharmaceuticals Inc (IDRA)

      7. Idera Pharmaceuticals Inc (IDRA) News

      IDRA

      Idera Pharmaceuticals (IDRA)

      Idera Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:IDRA
      DateTimeSourceHeadlineSymbolCompany
      09/28/20208:45AMGlobeNewswire Inc.Idera Pharmaceuticals Announces New U.S. Patent Coverage for Tilsotolimod Through September 2037NASDAQ:IDRAIdera Pharmaceuticals Inc
      09/28/20208:30AMInvestorsHub NewsWireImminent Reverse Merger Brings Windfall To Rafarma Pharmaceuticals Shareholders - RAFA Shares Could Surprise BigNASDAQ:IDRAIdera Pharmaceuticals Inc
      09/15/20207:18AMGlobeNewswire Inc.Idera Pharmaceuticals to Present Tilsotolimod Data at ESMO Virtual Congress 2020NASDAQ:IDRAIdera Pharmaceuticals Inc
      09/04/20207:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
      09/04/20207:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
      09/03/20208:37AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
      09/03/20208:26AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:IDRAIdera Pharmaceuticals Inc
      09/02/20205:21PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:IDRAIdera Pharmaceuticals Inc
      09/02/20205:19PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:IDRAIdera Pharmaceuticals Inc
      08/17/20204:31PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:IDRAIdera Pharmaceuticals Inc
      08/17/20206:26AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:IDRAIdera Pharmaceuticals Inc
      08/04/20205:14PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:IDRAIdera Pharmaceuticals Inc
      08/04/20205:10PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:IDRAIdera Pharmaceuticals Inc
      08/04/20204:32PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
      08/04/20204:25PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IDRAIdera Pharmaceuticals Inc
      08/04/20204:10PMGlobeNewswire Inc.Idera Pharmaceuticals Reports Second Quarter Financial Results and Provides Corporate UpdateNASDAQ:IDRAIdera Pharmaceuticals Inc
      07/23/20204:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
      07/23/20204:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
      07/23/20204:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
      07/23/20204:36PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
      07/23/20204:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
      07/15/20206:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
      07/15/20208:15AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
      07/15/20208:05AMGlobeNewswire Inc.Idera Pharmaceuticals Announces Private Placement of up to $20.0 MillionNASDAQ:IDRAIdera Pharmaceuticals Inc
      06/15/20204:32PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
      06/12/20206:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:IDRAIdera Pharmaceuticals Inc
      06/02/20208:34AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
      06/02/20208:27AMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:IDRAIdera Pharmaceuticals Inc
      06/02/20208:15AMGlobeNewswire Inc.Idera Pharmaceuticals Announces Preliminary Data From and Planned Continuation of the ILLUMINATE-206 Trial for the Treatment ...NASDAQ:IDRAIdera Pharmaceuticals Inc
      05/19/20207:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:IDRA